<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for no_benefit 1440013760793 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION'>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</a></td><td><a href='HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION.html'>Details ...</a></td><td>158</td><td>-0.46</td><td>-1.90</td><td>0.000</td><td>0.001</td><td>0.002</td><td>4109</td><td>tags=54%, list=29%, signal=75%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_NOTCH_SIGNALING'>HALLMARK_NOTCH_SIGNALING</a></td><td><a href='HALLMARK_NOTCH_SIGNALING.html'>Details ...</a></td><td>29</td><td>-0.53</td><td>-1.70</td><td>0.002</td><td>0.009</td><td>0.043</td><td>3123</td><td>tags=52%, list=22%, signal=66%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ANGIOGENESIS'>HALLMARK_ANGIOGENESIS</a></td><td><a href='HALLMARK_ANGIOGENESIS.html'>Details ...</a></td><td>25</td><td>-0.51</td><td>-1.59</td><td>0.024</td><td>0.025</td><td>0.168</td><td>2520</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_TGF_BETA_SIGNALING'>HALLMARK_TGF_BETA_SIGNALING</a></td><td><a href='HALLMARK_TGF_BETA_SIGNALING.html'>Details ...</a></td><td>51</td><td>-0.44</td><td>-1.55</td><td>0.012</td><td>0.027</td><td>0.226</td><td>4091</td><td>tags=41%, list=29%, signal=58%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_WNT_BETA_CATENIN_SIGNALING'>HALLMARK_WNT_BETA_CATENIN_SIGNALING</a></td><td><a href='HALLMARK_WNT_BETA_CATENIN_SIGNALING.html'>Details ...</a></td><td>35</td><td>-0.45</td><td>-1.50</td><td>0.041</td><td>0.039</td><td>0.380</td><td>2393</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MITOTIC_SPINDLE'>HALLMARK_MITOTIC_SPINDLE</a></td><td><a href='HALLMARK_MITOTIC_SPINDLE.html'>Details ...</a></td><td>196</td><td>-0.34</td><td>-1.43</td><td>0.005</td><td>0.067</td><td>0.635</td><td>6086</td><td>tags=55%, list=44%, signal=96%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UV_RESPONSE_DN'>HALLMARK_UV_RESPONSE_DN</a></td><td><a href='HALLMARK_UV_RESPONSE_DN.html'>Details ...</a></td><td>127</td><td>-0.34</td><td>-1.37</td><td>0.024</td><td>0.100</td><td>0.838</td><td>2625</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_E2F_TARGETS'>HALLMARK_E2F_TARGETS</a></td><td><a href='HALLMARK_E2F_TARGETS.html'>Details ...</a></td><td>193</td><td>-0.31</td><td>-1.33</td><td>0.022</td><td>0.133</td><td>0.943</td><td>5783</td><td>tags=48%, list=41%, signal=80%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYOGENESIS'>HALLMARK_MYOGENESIS</a></td><td><a href='HALLMARK_MYOGENESIS.html'>Details ...</a></td><td>118</td><td>-0.31</td><td>-1.28</td><td>0.080</td><td>0.180</td><td>0.987</td><td>4352</td><td>tags=42%, list=31%, signal=61%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYC_TARGETS_V1'>HALLMARK_MYC_TARGETS_V1</a></td><td><a href='HALLMARK_MYC_TARGETS_V1.html'>Details ...</a></td><td>197</td><td>-0.28</td><td>-1.18</td><td>0.146</td><td>0.353</td><td>1.000</td><td>6035</td><td>tags=49%, list=43%, signal=85%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UNFOLDED_PROTEIN_RESPONSE'>HALLMARK_UNFOLDED_PROTEIN_RESPONSE</a></td><td><a href='HALLMARK_UNFOLDED_PROTEIN_RESPONSE.html'>Details ...</a></td><td>107</td><td>-0.28</td><td>-1.13</td><td>0.250</td><td>0.435</td><td>1.000</td><td>4534</td><td>tags=36%, list=32%, signal=54%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_G2M_CHECKPOINT'>HALLMARK_G2M_CHECKPOINT</a></td><td><a href='HALLMARK_G2M_CHECKPOINT.html'>Details ...</a></td><td>194</td><td>-0.25</td><td>-1.06</td><td>0.362</td><td>0.584</td><td>1.000</td><td>6738</td><td>tags=54%, list=48%, signal=102%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_DNA_REPAIR'>HALLMARK_DNA_REPAIR</a></td><td><a href='HALLMARK_DNA_REPAIR.html'>Details ...</a></td><td>136</td><td>-0.26</td><td>-1.05</td><td>0.379</td><td>0.559</td><td>1.000</td><td>4878</td><td>tags=39%, list=35%, signal=59%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYC_TARGETS_V2'>HALLMARK_MYC_TARGETS_V2</a></td><td><a href='HALLMARK_MYC_TARGETS_V2.html'>Details ...</a></td><td>58</td><td>-0.28</td><td>-1.05</td><td>0.408</td><td>0.541</td><td>1.000</td><td>6187</td><td>tags=50%, list=44%, signal=89%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HEDGEHOG_SIGNALING'>HALLMARK_HEDGEHOG_SIGNALING</a></td><td><a href='HALLMARK_HEDGEHOG_SIGNALING.html'>Details ...</a></td><td>24</td><td>-0.31</td><td>-0.96</td><td>0.527</td><td>0.707</td><td>1.000</td><td>4469</td><td>tags=46%, list=32%, signal=67%</td></tr><tr><td class='lessen'>16</td><td><a href='http://cancerimmunity.org/peptide/tumor-specific/'>CANCER_IMMUNITY_SHARED_TUMOR_SPECIFIC_ANTIGENS</a></td><td><a href='CANCER_IMMUNITY_SHARED_TUMOR_SPECIFIC_ANTIGENS.html'>Details ...</a></td><td>2</td><td>-0.58</td><td>-0.89</td><td>0.653</td><td>0.825</td><td>1.000</td><td>3382</td><td>tags=50%, list=24%, signal=66%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_SURFACE'>HALLMARK_APICAL_SURFACE</a></td><td><a href='HALLMARK_APICAL_SURFACE.html'>Details ...</a></td><td>29</td><td>-0.27</td><td>-0.85</td><td>0.696</td><td>0.858</td><td>1.000</td><td>926</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_SPERMATOGENESIS'>HALLMARK_SPERMATOGENESIS</a></td><td><a href='HALLMARK_SPERMATOGENESIS.html'>Details ...</a></td><td>64</td><td>-0.21</td><td>-0.80</td><td>0.807</td><td>0.886</td><td>1.000</td><td>3829</td><td>tags=30%, list=27%, signal=41%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_JUNCTION'>HALLMARK_APICAL_JUNCTION</a></td><td><a href='HALLMARK_APICAL_JUNCTION.html'>Details ...</a></td><td>136</td><td>-0.18</td><td>-0.75</td><td>0.907</td><td>0.897</td><td>1.000</td><td>926</td><td>tags=10%, list=7%, signal=11%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>no_benefit (16 samples)<b>&nbsp<a href='gsea_report_for_no_benefit_1440013760793.xls'>[plain text format]</a></caption></table></div><br></body></html>